ZimVie Inc. announced it has received FDA clearance for its Vital Spinal Fixation System including instruments for use with Brainlab Spine & Trauma Navigation. This follows the execution of the companies' Development Cooperation Agreement, announced in March 2023, to achieve compatibility between ZimVie's Vital and Virage®? systems and Brainlab Spine &Trauma Navigation, which helps surgeons plan and execute spinal procedures, accurately place pedicle screws, and minimize radiation exposure.

ZimVie plans to co-market Brainlab Spine & Tra trauma Navigation alongside its Vital and Virage lines, with first Vital sets expected to be launched in the United States in early 2024. Having secured that clearance, the company plans to submit a 510(k) application to the FDA for Virage next year, as well. The Vital Spinal Fixation System includes an optimized instrument and implant kit configuration for complex anddegenerative thoracolumbar procedures designed to provide surgeons with the flexibility to utilize instrumentation based on their personal technique, preference and specific patient needs.

A series of instruments and reference arrays designed to be compatible with Brainlab spine and trauma navigation technologies allows navigation during bone preparation and placement of pedicle screws during spinal surgery to assist the surgeon in precisely locating anatomical structures in either open or minimally invasive procedures.